Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Drug Resistance

  Free Subscription


Articles published in AIDS

Retrieve available abstracts of 15 articles:
HTML format



Single Articles


    September 2025
  1. NAIK V, Nekkalapudi A, Boopathy AV, Falkard B, et al
    Emergence of in vitro resistance to lenacapavir is similar across HIV-1 subtypes.
    AIDS. 2025 Sep 18. doi: 10.1097/QAD.0000000000004334.
    PubMed     Abstract available


    June 2025
  2. MERAD Y, Mariaggi AA, Karmochkine M, Slama L, et al
    Virological success despite archived INSTI drug resistance mutations on INSTI-based antiretroviral regimens.
    AIDS. 2025 Jun 5. doi: 10.1097/QAD.0000000000004251.
    PubMed     Abstract available


    May 2025
  3. CLEMENTE T, Bellomo M, Raccagni AR, Lolatto R, et al
    Sexually transmitted infections in men who have sex with men with tenofovir/emtricitabine- or cabotegravir-resistant HIV.
    AIDS. 2025 May 3. doi: 10.1097/QAD.0000000000004225.
    PubMed     Abstract available


    April 2025
  4. ZHANG R, Chung SL, Lee SS, Wong NS, et al
    Prevalence and resistance patterns of Mycoplasma genitalium infection in people living with HIV: a systematic review and meta-analysis.
    AIDS. 2025 Apr 22. doi: 10.1097/QAD.0000000000004219.
    PubMed     Abstract available


  5. GLENN JS, Bennett A, Mackie N, Lyall H, et al
    The cumulative prevalence of HIV-1 drug resistance in perinatal HIV.
    AIDS. 2025 Apr 4. doi: 10.1097/QAD.0000000000004202.
    PubMed     Abstract available


    March 2025
  6. MUCCINI C, Spagnuolo V, Zazzi M, Castagna A, et al
    People with four-class drug-resistant HIV-1 may have low levels of intact DNA.
    AIDS. 2025;39:475-476.
    PubMed     Abstract available


  7. INZAULE S, Jordan MR, Fokam J, Hamers RL, et al
    Non-canonical HIV drug resistance mutations: need to close existing gaps.
    AIDS. 2025 Mar 6. doi: 10.1097/QAD.0000000000004170.
    PubMed     Abstract available


    February 2025
  8. WAGNER T, Levy I, Wieder-Finesod A, Wax M, et al
    Drug resistance testing at regimen failure in individuals diagnosed with HIV-1 between 2010 and 2018 in Israel.
    AIDS. 2025 Feb 3. doi: 10.1097/QAD.0000000000004138.
    PubMed     Abstract available


    October 2024
  9. ENI-OLUTU A, Mackie NE, Glenn J, Bailey A, et al
    Emerging integrase resistance in an international perinatal virtual clinic.
    AIDS. 2024 Oct 28. doi: 10.1097/QAD.0000000000004048.
    PubMed     Abstract available


  10. CLEMENTE T, Pontillo D, Malagnino V, Calza L, et al
    Cancer in people with multidrug-resistant HIV.
    AIDS. 2024;38:1801-1806.
    PubMed     Abstract available


    September 2024
  11. ZANIEWSKI E, Skrivankova VW, Brazier E, Avihingsanon A, et al
    Transition to dolutegravir-based ART in 35 low- and middle-income countries: a global survey of HIV care clinics.
    AIDS. 2024 Sep 5. doi: 10.1097/QAD.0000000000004007.
    PubMed     Abstract available


  12. BURGER D, Wttewaal E, Oosterhof P, Stalenhoef J, et al
    Concomitant use of anabolic androgen steroids and cabotegravir/rilpivirine leading to virological failure and development of two-class resistance.
    AIDS. 2024;38:1728-1729.
    PubMed    


    July 2024
  13. KARABAY O
    Concerns and clarifications regarding the article 'Virological, weight, and drug resistance outcomes among patients initiating a dolutegravir-based first line ART regimen in Zimbabwe'.
    AIDS. 2024;38:1273.
    PubMed    


    March 2024
  14. PAPAIOANNU BORJESSON R, Galli L, Lolatto R, Menzaghi B, et al
    Lower aids-related hospitalizations in women living with HIV multidrug resistance.
    AIDS. 2024;38:435-438.
    PubMed    


    February 2024
  15. GONCALVES P, Barreto J, Santos M, Leal S, et al
    HIV-1 drug resistance and genetic diversity in people with HIV-1 in Cape Verde, 2019-2021.
    AIDS. 2024 Feb 13. doi: 10.1097/QAD.0000000000003866.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Drug Resistance is free of charge.